{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T09:12:38Z","timestamp":1780391558599,"version":"3.54.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:00:00Z","timestamp":1780358400000},"content-version":"vor","delay-in-days":71,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["Z01-BC006161"],"award-info":[{"award-number":["Z01-BC006161"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The non-tumor tissue adjacent to metastases can appear morphologically unremarkable under a microscope; however, it is exposed to a milieu of secretory factors and proteins derived from tumor cells, stromal cells, and immune cells within the surrounding tumor microenvironment. Studies investigating the peritumoral tissue (PTT) or so-called Normal tissue Adjacent to Tumor tissue (NAT) have identified distinct differences between the genomic and transcriptomic profiles of healthy and tumor-adjacent non-tumor tissues. These alterations are hypothesized to have significant implications in local tumor progression, metastasis, and patient outcome. Most NAT\/PTT studies focus on the primary tumor microenvironment (TME) with comparisons between patients with and without cancer. The study described herein expands upon this work by investigating the metastatic TME with comparisons between met-recipient and met-free tissues, both derived from a canine osteosarcoma clinical trial. Our study identifies shared and tissue-specific changes in met-recipient non-tumor lung, liver, and kidney which overlap with transcriptional alterations described in human cancers. These findings improve our understanding of the landscape of the peritumoral TME of metastatic osteosarcoma and further underscore the translational relevance of the canine patient as a model of human disease.<\/jats:p>","DOI":"10.1038\/s42003-026-09870-x","type":"journal-article","created":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T23:11:55Z","timestamp":1774307515000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comprehensive analysis of non-tumor lung, liver, and kidney transcriptomes in canine metastatic osteosarcoma"],"prefix":"10.1038","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0145-7606","authenticated-orcid":false,"given":"Jessica A.","family":"Beck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9981-3607","authenticated-orcid":false,"given":"Anjali","family":"Garg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter L.","family":"Choyke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Mazcko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7656-9859","authenticated-orcid":false,"given":"Amy K.","family":"LeBlanc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,23]]},"reference":[{"key":"9870_CR1","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/s41572-022-00409-y","volume":"8","author":"HC Beird","year":"2022","unstructured":"Beird, H. C. et al. Osteosarcoma. Nat. Rev. Dis. Prim. 8, 77 (2022).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"9870_CR2","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1093\/annonc\/mdn731","volume":"20","author":"AH Aljubran","year":"2009","unstructured":"Aljubran, A. H., Griffin, A., Pintilie, M. & Blackstein, M. Osteosarcoma in adolescents and adults: survival analysis with and without lung metastases. Ann. Oncol. 20, 1136\u20131141 (2009).","journal-title":"Ann. Oncol."},{"key":"9870_CR3","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/s41392-023-01460-1","volume":"8","author":"ZL Liu","year":"2023","unstructured":"Liu, Z. L., Chen, H. H., Zheng, L. L., Sun, L. P. & Shi, L. Angiogenic signaling pathways and anti-angiogenic therapy for cancer. Signal Transduct. Target Ther. 8, 198 (2023).","journal-title":"Signal Transduct. Target Ther."},{"key":"9870_CR4","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1038\/s12276-023-01013-0","volume":"55","author":"D Yang","year":"2023","unstructured":"Yang, D., Liu, J., Qian, H. & Zhuang, Q. Cancer-associated fibroblasts: from basic science to anticancer therapy. Exp. Mol. Med. 55, 1322\u20131332 (2023).","journal-title":"Exp. Mol. Med"},{"key":"9870_CR5","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.semcancer.2022.03.014","volume":"86","author":"S Gaikwad","year":"2022","unstructured":"Gaikwad, S., Agrawal, M. Y., Kaushik, I., Ramachandran, S. & Srivastava, S. K. Immune checkpoint proteins: signaling mechanisms and molecular interactions in cancer immunotherapy. Semin Cancer Biol. 86, 137\u2013150 (2022).","journal-title":"Semin Cancer Biol."},{"key":"9870_CR6","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/s41571-023-00754-1","volume":"20","author":"KM Cappell","year":"2023","unstructured":"Cappell, K. M. & Kochenderfer, J. N. Long-term outcomes following CAR T cell therapy: what we know so far. Nat. Rev. Clin. Oncol. 20, 359\u2013371 (2023).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"9870_CR7","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1177\/03009858221083038","volume":"59","author":"J Beck","year":"2022","unstructured":"Beck, J. et al. Canine and Murine models of osteosarcoma. Vet. Pathol. 59, 399\u2013414 (2022).","journal-title":"Vet. Pathol."},{"key":"9870_CR8","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/s41568-020-0297-3","volume":"20","author":"AK LeBlanc","year":"2020","unstructured":"LeBlanc, A. K. & Mazcko, C. N. Improving human cancer therapy through the evaluation of pet dogs. Nat. Rev. Cancer 20, 727\u2013742 (2020).","journal-title":"Nat. Rev. Cancer"},{"key":"9870_CR9","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1111\/vco.12927","volume":"21","author":"KI Silver","year":"2023","unstructured":"Silver, K. I. et al. Patterns of metastatic progression and association with clinical outcomes in canine osteosarcoma: A necropsy study of 83 dogs. Vet. Comp. Oncol. 21, 646\u2013655 (2023).","journal-title":"Vet. Comp. Oncol."},{"key":"9870_CR10","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/pbc.10420","volume":"42","author":"SN Chi","year":"2004","unstructured":"Chi, S. N. et al. The patterns of relapse in osteosarcoma: the Memorial Sloan-Kettering experience. Pediatr. Blood Cancer 42, 46\u201351 (2004).","journal-title":"Pediatr. Blood Cancer"},{"key":"9870_CR11","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/bjc.1975.136","volume":"32","author":"GM Jeffree","year":"1975","unstructured":"Jeffree, G. M., Price, C. H. & Sissons, H. A. The metastatic patterns of osteosarcoma. Br. J. Cancer 32, 87\u2013107 (1975).","journal-title":"Br. J. Cancer"},{"key":"9870_CR12","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1038\/s41416-024-02828-y","volume":"131","author":"D Koca","year":"2024","unstructured":"Koca, D., Abedi-Ardekani, B., LeMaoult, J. & Guyon, L. Peritumoral tissue (PTT): increasing need for naming convention. Br. J. Cancer 131, 1111\u20131115 (2024).","journal-title":"Br. J. Cancer"},{"key":"9870_CR13","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-017-01027-z","volume":"8","author":"D Aran","year":"2017","unstructured":"Aran, D. et al. Comprehensive analysis of normal adjacent to tumor transcriptomes. Nat. Commun. 8, 1077 (2017).","journal-title":"Nat. Commun."},{"key":"9870_CR14","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s10549-009-0504-0","volume":"118","author":"CM Heaphy","year":"2009","unstructured":"Heaphy, C. M., Griffith, J. K. & Bisoffi, M. Mammary field cancerization: molecular evidence and clinical importance. Breast Cancer Res Treat. 118, 229\u2013239 (2009).","journal-title":"Breast Cancer Res Treat."},{"key":"9870_CR15","volume":"26","author":"PM Morla-Barcelo","year":"2024","unstructured":"Morla-Barcelo, P. M. et al. Unraveling malignant phenotype of peritumoral tissue: transcriptomic insights into early-stage breast cancer. Breast Cancer Res. 26, 89 (2024).","journal-title":"Breast Cancer Res."},{"key":"9870_CR16","doi-asserted-by":"crossref","first-page":"7020","DOI":"10.1158\/1078-0432.CCR-09-1126","volume":"15","author":"MA Troester","year":"2009","unstructured":"Troester, M. A. et al. Activation of host wound responses in breast cancer microenvironment. Clin. Cancer Res. 15, 7020\u20137028 (2009).","journal-title":"Clin. Cancer Res."},{"key":"9870_CR17","volume":"21","author":"J Kim","year":"2023","unstructured":"Kim, J. et al. Transcriptomes of the tumor-adjacent normal tissues are more informative than tumors in predicting recurrence in colorectal cancer patients. J. Transl. Med. 21, 209 (2023).","journal-title":"J. Transl. Med."},{"key":"9870_CR18","doi-asserted-by":"crossref","first-page":"5191","DOI":"10.7150\/ijbs.99734","volume":"20","author":"Y Hou","year":"2024","unstructured":"Hou, Y. et al. Integrated analysis of tumor and adjacent non-tumor proteomic data reveals SERPINH1 as a recurrence biomarker and drug target in hepatocellular carcinoma. Int. J. Biol. Sci. 20, 5191\u20135207 (2024).","journal-title":"Int. J. Biol. Sci."},{"key":"9870_CR19","doi-asserted-by":"crossref","unstructured":"Michot, A. et al. Analysis of the peritumoral tissue unveils cellular changes associated with a high risk of recurrence. Cancers (Basel) 15, 3450 (2023).","DOI":"10.3390\/cancers15133450"},{"key":"9870_CR20","volume":"6","author":"X Huang","year":"2016","unstructured":"Huang, X., Stern, D. F. & Zhao, H. Transcriptional profiles from paired normal samples offer complementary information on cancer patient survival-evidence from TCGA pan-cancer data. Sci. Rep. 6, 20567 (2016).","journal-title":"Sci. Rep."},{"key":"9870_CR21","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1158\/1078-0432.CCR-21-0315","volume":"27","author":"AK LeBlanc","year":"2021","unstructured":"LeBlanc, A. K. et al. Adjuvant sirolimus does not improve outcome in pet dogs receiving standard-of-care therapy for appendicular osteosarcoma: a prospective, randomized trial of 324 dogs. Clin. Cancer Res. 27, 3005\u20133016 (2021).","journal-title":"Clin. Cancer Res."},{"key":"9870_CR22","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.12669\/pjms.305.5534","volume":"30","author":"S Hassan","year":"2014","unstructured":"Hassan, S., Syed, S. & Kehar, S. I. Glial fibrillary acidic protein (GFAP) as a mesenchymal marker of early hepatic stellate cells activation in liver fibrosis in chronic hepatitis C infection. Pak. J. Med Sci. 30, 1027\u20131032 (2014).","journal-title":"Pak. J. Med Sci."},{"key":"9870_CR23","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1016\/j.micinf.2006.04.009","volume":"8","author":"S Mulugeta","year":"2006","unstructured":"Mulugeta, S. & Beers, M. F. Surfactant protein C: its unique properties and emerging immunomodulatory role in the lung. Microbes Infect. 8, 2317\u20132323 (2006).","journal-title":"Microbes Infect."},{"key":"9870_CR24","doi-asserted-by":"crossref","unstructured":"Patkar, S. et al. Large-scale comparative analysis of canine and human osteosarcomas uncovers conserved clinically relevant tumor microenvironment subtypes. Clin. Cancer Res. 30, 5630\u20135642 (2024).","DOI":"10.1158\/1078-0432.CCR-24-1854"},{"key":"9870_CR25","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1158\/0008-5472.CAN-24-3723","volume":"85","author":"J Eigenbrood","year":"2025","unstructured":"Eigenbrood, J. et al. Spatial profiling identifies regionally distinct microenvironments and targetable immunosuppressive mechanisms in pediatric osteosarcoma pulmonary metastases. Cancer Res. 85, 2320\u20132337 (2025).","journal-title":"Cancer Res."},{"key":"9870_CR26","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1038\/s42003-024-06182-w","volume":"7","author":"DT Ammons","year":"2024","unstructured":"Ammons, D. T. et al. Single-cell RNA sequencing reveals the cellular and molecular heterogeneity of treatment-naive primary osteosarcoma in dogs. Commun. Biol. 7, 496 (2024).","journal-title":"Commun. Biol."},{"key":"9870_CR27","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1016\/j.ajpath.2021.08.004","volume":"191","author":"M-J Kang","year":"2021","unstructured":"Kang, M.-J. et al. Inhibition of hepatic stellate cell activation suppresses tumorigenicity of hepatocellular carcinoma in mice.  Am. J. Pathol. 191, 2219\u20132230 (2021).","journal-title":"Am. J. Pathol."},{"key":"9870_CR28","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/hep.24384","volume":"54","author":"N Kang","year":"2011","unstructured":"Kang, N., Gores, G. J. & Shah, V. H. Hepatic stellate cells: partners in crime for liver metastases? Hepatology 54, 707\u2013713 (2011).","journal-title":"Hepatology"},{"key":"9870_CR29","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/s41575-023-00821-z","volume":"20","author":"B Cogliati","year":"2023","unstructured":"Cogliati, B., Yashaswini, C. N., Wang, S., Sia, D. & Friedman, S. L. Friend or foe? The elusive role of hepatic stellate cells in liver cancer. Nat. Rev. Gastroenterol. Hepatol. 20, 647\u2013661 (2023).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"9870_CR30","doi-asserted-by":"crossref","DOI":"10.1186\/s40348-022-00136-0","volume":"9","author":"A Kiefer","year":"2022","unstructured":"Kiefer, A. et al. DMBT1 is upregulated in cystic fibrosis, affects ciliary motility, and is reduced by acetylcysteine. Mol. Cell. Pediatr. 9, 4 (2022).","journal-title":"Mol. Cell. Pediatr."},{"key":"9870_CR31","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.3390\/ijms22052566","volume":"22","author":"B Ruaro","year":"2021","unstructured":"Ruaro, B. et al. The history and mystery of alveolar epithelial type II cells: focus on their physiologic and pathologic role in lung. Int. J. Mol. Sci. 22, 2566 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"9870_CR32","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/s42003-025-07992-2","volume":"8","author":"LE McGee","year":"2025","unstructured":"McGee, L. E. et al. The tumor microenvironment of metastatic osteosarcoma in the human and canine lung. Commun. Biol. 8, 756 (2025).","journal-title":"Commun. Biol."},{"key":"9870_CR33","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1158\/1078-0432.CCR-24-0049","volume":"31","author":"JB Reinecke","year":"2025","unstructured":"Reinecke, J. B. et al. Aberrant activation of wound-healing programs within the metastatic niche facilitates lung colonization by osteosarcoma cells. Clin. Cancer Res. 31, 414\u2013429 (2025).","journal-title":"Clin. Cancer Res."},{"key":"9870_CR34","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.4049\/jimmunol.1800619","volume":"202","author":"DP Regan","year":"2019","unstructured":"Regan, D. P. et al. The angiotensin receptor blocker losartan suppresses growth of pulmonary metastases via AT1R-independent inhibition of CCR2 signaling and monocyte recruitment. J. Immunol. 202, 3087\u20133102 (2019).","journal-title":"J. Immunol."},{"key":"9870_CR35","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1158\/1078-0432.CCR-21-2105","volume":"28","author":"DP Regan","year":"2022","unstructured":"Regan, D. P. et al. Losartan blocks osteosarcoma-elicited monocyte recruitment, and combined with the kinase inhibitor toceranib, exerts significant clinical benefit in canine metastatic osteosarcoma. Clin. Cancer Res. 28, 662\u2013676 (2022).","journal-title":"Clin. Cancer Res."},{"key":"9870_CR36","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1130215","volume":"13","author":"M Klosowski","year":"2023","unstructured":"Klosowski, M. et al. Naturally occurring canine sarcomas: bridging the gap from mouse models to human patients through cross-disciplinary research partnerships. Front Oncol. 13, 1130215 (2023).","journal-title":"Front Oncol."},{"key":"9870_CR37","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/bjc.2015.193","volume":"113","author":"SC Wightman","year":"2015","unstructured":"Wightman, S. C. et al. Oncogenic CXCL10 signalling drives metastasis development and poor clinical outcome. Br. J. Cancer 113, 327\u2013335 (2015).","journal-title":"Br. J. Cancer"},{"key":"9870_CR38","doi-asserted-by":"crossref","first-page":"583","DOI":"10.3892\/ol.2011.300","volume":"2","author":"M Liu","year":"2011","unstructured":"Liu, M., Guo, S. & Stiles, J. K. The emerging role of CXCL10 in cancer (Review). Oncol. Lett. 2, 583\u2013589 (2011).","journal-title":"Oncol. Lett."},{"key":"9870_CR39","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/cncr.30272","volume":"123","author":"RJ Flores","year":"2017","unstructured":"Flores, R. J. et al. A novel prognostic model for osteosarcoma using circulating CXCL10 and FLT3LG. Cancer 123, 144\u2013154 (2017).","journal-title":"Cancer"},{"key":"9870_CR40","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ctrv.2017.11.007","volume":"63","author":"R Tokunaga","year":"2018","unstructured":"Tokunaga, R. et al. CXCL9, CXCL10, CXCL11\/CXCR3 axis for immune activation - A target for novel cancer therapy. Cancer Treat. Rev. 63, 40\u201347 (2018).","journal-title":"Cancer Treat. Rev."},{"key":"9870_CR41","first-page":"861","volume":"142","author":"Y Ohmori","year":"1993","unstructured":"Ohmori, Y. et al. Tumor necrosis factor-alpha induces cell type and tissue-specific expression of chemoattractant cytokines in vivo. Am. J. Pathol. 142, 861\u2013870 (1993).","journal-title":"Am. J. Pathol."},{"key":"9870_CR42","doi-asserted-by":"crossref","first-page":"14899","DOI":"10.1074\/jbc.272.23.14899","volume":"272","author":"Y Ohmori","year":"1997","unstructured":"Ohmori, Y., Schreiber, R. D. & Hamilton, T. A. Synergy between interferon-gamma and tumor necrosis factor-alpha in transcriptional activation is mediated by cooperation between signal transducer and activator of transcription 1 and nuclear factor kappaB. J. Biol. Chem. 272, 14899\u201314907 (1997).","journal-title":"J. Biol. Chem."},{"key":"9870_CR43","doi-asserted-by":"crossref","first-page":"e1000161","DOI":"10.1371\/journal.pmed.1000161","volume":"6","author":"I Gordon","year":"2009","unstructured":"Gordon, I., Paoloni, M., Mazcko, C. & Khanna, C. The comparative oncology trials consortium: using spontaneously occurring cancers in dogs to inform the cancer drug development pathway. PLoS Med. 6, e1000161 (2009).","journal-title":"PLoS Med"},{"key":"9870_CR44","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.tvjl.2010.04.019","volume":"185","author":"M Paoloni","year":"2010","unstructured":"Paoloni, M., Lana, S., Thamm, D., Mazcko, C. & Withrow, S. The creation of the comparative oncology trials consortium pharmacodynamic core: infrastructure for a virtual laboratory. Vet. J. 185, 88\u201389 (2010).","journal-title":"Vet. J."},{"key":"9870_CR45","doi-asserted-by":"crossref","first-page":"e0153844","DOI":"10.1371\/journal.pone.0153844","volume":"11","author":"A Talhouk","year":"2016","unstructured":"Talhouk, A. et al. Single-patient molecular testing with nanostring ncounter data using a reference-based strategy for batch effect correction. PLoS One 11, e0153844 (2016).","journal-title":"PLoS One"},{"key":"9870_CR46","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","volume":"26","author":"MD Robinson","year":"2010","unstructured":"Robinson, M. D., McCarthy, D. J. & Smyth, G. K. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 26, 139\u2013140 (2010).","journal-title":"Bioinformatics"},{"key":"9870_CR47","volume":"2","author":"T Wu","year":"2021","unstructured":"Wu, T. et al. clusterProfiler 4.0: a universal enrichment tool for interpreting omics data. Innov. (Camb.) 2, 100141 (2021).","journal-title":"Innov. (Camb.)"},{"key":"9870_CR48","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu, G., Wang, L. G., Han, Y. & He, Q. Y. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 16, 284\u2013287 (2012).","journal-title":"OMICS"},{"key":"9870_CR49","volume":"17","author":"E Becht","year":"2016","unstructured":"Becht, E. et al. Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression. Genome Biol. 17, 218 (2016).","journal-title":"Genome Biol."},{"key":"9870_CR50","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s41587-023-01767-y","volume":"42","author":"Y Hao","year":"2024","unstructured":"Hao, Y. et al. Dictionary learning for integrative, multimodal and scalable single-cell analysis. Nat. Biotechnol. 42, 293\u2013304 (2024).","journal-title":"Nat. Biotechnol."}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-09870-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-09870-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-09870-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T08:33:05Z","timestamp":1780389185000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-09870-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,23]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9870"],"URL":"https:\/\/doi.org\/10.1038\/s42003-026-09870-x","relation":{},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,23]]},"assertion":[{"value":"28 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"741"}}